ICH Q5A(R2) | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

12,116 results for “ICH Q5A(R2)”

Trials

View all 11189 →

Vscan Access R2 Feasibility Evaluation

16 participants · First posted Aug 6, 2018

RAINBOW-ICH Trial of AI Guided Minimally Invasive Neurosurgery for ICH

1,000 participants · First posted Oct 3, 2025

177Lu-PSMA-R2 in Patients With PSMA Positive Progressive, Metastatic, Castration Resistant Prostate Cancer

27 participants · First posted Apr 6, 2018

Drugs

View all 621 →

ICH-0323

ICH-65

sTNF-R2

Organizations

View all 18 →

Lion-CM CSI Div CNY

ICN PHARMACEUTICALS

India

Ico Therapeutics Inc.

Canada

News

View all 288 →

Viral Clearance Market Projected to Reach USD 4.8 Billion by 2036, Driven by Expanding Biologics Pipelines and Updated Regulatory Guidance

Early QC Planning Is the Make-or-Break Factor in Cell and Gene Therapy Development

ICH Updates Guidelines: NGS Becomes New Standard for Viral Safety Testing in Biotech Manufacturing

Page 1 of 1212